[Advances in pharmacotherapy of arteriosclerosis].
Balewska
K
K
Pracowni Cytologicznej Wojewódzkiego Szpitala Zespolonego w Lomzy.
Witanowska
A
A
D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D002994:Clofibrate / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008148:Lovastatin / Q000627:therapeutic use; D009525:Niacin / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use
D000960:Hypolipidemic Agents; D009525:Niacin; D008148:Lovastatin; D002994:Clofibrate; D003084:Colestipol; D011341:Probucol
Postepy farmakoterapii miazdzycy.